Safinamide mesylate
Synonym(s):(S)-(+)-2-[[4-(3-Fluorobenzoxy)benzyl]amino]propanamide; (S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide; FCE-26743; PNU-151774E, NW-1015;
- CAS NO.:202825-46-5
- Empirical Formula: C17H19FN2O2.CH4O3S
- Molecular Weight: 398.4490232
- MDL number: MFCD15145475
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-11-07 17:34:29
What is Safinamide mesylate?
Description
Safinamide methanesulfonate was approved in February 2015 by the EMA for the treatment of mid- to late-stage fluctuating Parkinson’s disease. This approval included use of the drug as an add-on therapy for use with levodopa, either alone or in combination with other existing therapies for Parkinson’s disease.51 Safinamide methanesulfonate, an oral α-aminoamide originally discovered by Farmitalia Carlo Erba and later developed by Newron/Zambon, functions as a highly selective and reversible inhibitor of MAO-B, leading to increased levels of dopamine and subsequent improvement in the motor symptoms of Parkinson’s disease, side effects that often result from use of other traditional treatments relying on dopamine replacement therapy.
The Uses of Safinamide mesylate
Safinamide mesylate salt has been used as a reference drug to study its inhibitory effect on human monoamine oxidases (hMAO-A and hMAO-B).
What are the applications of Application
Safinamide mesylate is a potent and selective MAO-B inhibitor
Properties of Safinamide mesylate
Melting point: | 210° (dec) |
storage temp. | 2-8°C |
solubility | H2O: ≥15mg/mL |
form | powder |
color | white to tan |
Safety information for Safinamide mesylate
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 Health Hazard GHS08 |
GHS Hazard Statements |
H302:Acute toxicity,oral H319:Serious eye damage/eye irritation |
Precautionary Statement Codes |
P202:Do not handle until all safety precautions have been read and understood. P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P270:Do not eat, drink or smoke when using this product. P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. P308+P313:IF exposed or concerned: Get medical advice/attention. |
Computed Descriptors for Safinamide mesylate
Abamectin manufacturer
Honour Lab Limited
Solara Active Pharma Sciences Ltd
Biophore India Pharmaceuticals Pvt Ltd
Apicore Pharmaceuticals Pvt Ltd
Enaltec Labs Pvt Ltd
Shankus Pharmaceuticals
New Products
3-N-BOC-(S)-AMINO BUTYRONITRILE 4-Piperidinopiperidine 2-Methyl-4-nitrobenzoic acid 2-(4-bromophenyl)-2-methylpropanoic acid 4-Acetyl-2-methylbenzoicacid Acetyl-meldrum's acid Ethyl-4-Pyrazole carboxylate 2,6 Di acetylpyridine 2,6-Pyridinedimethanol 5,7-Dichloro-3H-Imidazo[4,5-B]Pyridine 5-Bromo-2-Methoxy-4-Methyl-3-Nitropyridine 2-Fluoro-5-Iodopyridine 2-Fluoro-5-Methylpyridine 2-Chloro-3-Bromo-5-Amiopyridine METHYL-4-(BUTYRYLAMINO)3-METHYL-5-NITROBENZOATE TRANS-CYCLOBUTANE-1,2- DICARBOXYLIC ACID 5-Nitro indazole R-(-)-5-(2-AMINO-PROPYL)-2-METHOXY-BENZENESULFONAMIDE 1,3-cyclohexanedione 4-Aminophenaethylalchol (S)-(+)-4-BENZYL-2-OXAZOLIDINONE 3-NITRO-5-ACETYL IMINODIBENZYL 1-HYDROXY-4-METHYL6-(2,4,4-TRI METHYL PHENYL)-2-PYRIDONE MONO ETHANOL AMINE(PIROCTONE OLAMINE) 4-FLUORO PHENYL MAGNESIUM BROMIDE 1.0 M IN THFRelated products of tetrahydrofuran
You may like
-
202825-46-5 Safinamide mesylate 98%View Details
202825-46-5 -
202825-46-5 98%View Details
202825-46-5 -
Safinamide mesylate 98%View Details
202825-46-5 -
Safinamide mesylate 202825-46-5 98%View Details
202825-46-5 -
202825-46-5 Safinamide mesylate 99%View Details
202825-46-5 -
Safinamide mesylate 98%View Details
202825-46-5 -
Desloratadine 99%View Details
100643-71-8 -
135046-48-9 99%View Details
135046-48-9